Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Biomarkers of Immune-Related Toxicity in Cancer Patients Treated With Immune Checkpoint Inhibitors; A Pilot Project

NCT03409016 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03409016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03409016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Biomarkers of Immune-Related Toxicity in Cancer Patients Treated With Immune Checkpoint Inhibitors; A Pilot Project
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Active, not recruiting
Start date
April 18, 2018
Completion date
October 17, 2026
Enrollment
69 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, metastatic cancer